marketcaparena
Search

    SRXH

    SRX Global Inc.

    Company overview

    Market capitalization
    $32.02M
    Employees
    10
    Latest publication
    2026-09-29
    About SRX Global Inc.

    SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally. The company offers pet health and wellness products in multiple forms, including kibble, canned food, freeze-dried raw food, treats, and supplements. The company also offers consumer products, including dry food, wet food, treats, and other premium pet products. The company also offers pharmacy services, patient support programs, diagnostic services, and clinical trials. The company was founded in 2013 and is headquartered in North Palm Beach, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Revenue3,392,000USD3,439,000USD2,807,000USD-34,548,000USD11,447,000USD7,159,000USD7,158,000USD11,372,000USD
    Cost Of Revenue2,488,000USD2,088,000USD1,768,000USD-25,778,000USD9,828,000USD4,776,000USD4,585,000USD6,885,000USD
    Gross Profit904,000USD1,351,000USD1,038,999USD-8,770,000USD1,619,000USD2,383,000USD2,573,000USD4,487,000USD
    Selling General Administrative4,105,000USD3,093,000USD4,844,000USD18,151,000USD18,151,000USD3,471,000USD0USD—
    Total Operating Expenses4,105,000USD3,169,000USD4,671,000USD-29,541,000USD16,351,000USD3,471,000USD4,222,000USD5,614,000USD
    Operating Income-3,201,000USD-1,818,000USD-3,632,000USD20,771,000USD-14,732,000USD-1,088,000USD-1,649,000USD-1,127,000USD
    Total Other Income Expense Net-939,000USD-4,561,000USD-4,978,000USD965,000USD-1,955,999USD126,000USD138,000USD2,651,000USD
    Interest Expense569,000USD1,780,000USD1,288,000USD1,333,936USD975,000USD—0USD—
    Income Before Tax-4,140,000USD-6,379,000USD-8,610,000USD21,736,000USD-16,687,999USD-962,000USD-1,511,000USD1,524,000USD
    Income Tax Expense0USD2,000USD4,000USD630,000USD-1,555,000USD2,000USD6,000USD-2,000USD
    Net Income-4,140,000USD-6,381,000USD-8,614,000USD-15,261,000USD-15,133,000USD-964,000USD-3,983,000USD1,526,000USD
    Net Income Applicable To Common Shares-4,140,000USD———————
    Net Interest Income—-1,780,000USD-1,288,000USD2,720,000USD—83,000USD0USD—
    Tax Provision—2,000USD4,000USD630,000USD—2,000USD0USD—
    Net Income From Continuing Ops—-6,381,000USD-8,614,000USD21,106,000USD—-964,000USD0USD—
    Ebit—-1,818,000USD-3,632,000USD-21,497,583USD-14,732,000USD-1,088,000USD0USD1,524,000USD
    Ebitda—-1,894,000USD-3,617,000USD-19,034,931USD-12,932,000USD-1,062,000USD920,000USD1,555,000USD
    Depreciation And Amortization—-76,000USD15,000USD2,462,652USD1,800,000USD26,000USD920,000USD31,000USD
    Reconciled Depreciation—-76,000USD15,000USD-2,892,000USD—26,000USD920,000USD—
    Unclassified Operating Expenses———-47,692,000USD-1,800,000USD—4,222,000USD5,614,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USD
    Total Revenue6,534,000USD34,975,000USD118,939,215USD92,630,832USD46,006,000USD42,590,000USD
    Cost Of Revenue5,039,000USD22,116,000USD95,328,513USD79,325,349USD32,302,000USD28,239,000USD
    Gross Profit1,495,000USD12,859,000USD23,610,702USD13,305,482USD13,704,000USD14,351,000USD
    Selling General Administrative12,932,000USD0USD26,545,382USD13,141,851USD——
    Total Operating Expenses13,025,000USD18,826,000USD29,418,217USD14,471,893USD30,983,000USD41,673,000USD
    Operating Income-11,530,000USD-5,967,000USD-5,807,515USD-1,166,410USD-17,279,000USD-27,322,000USD
    Interest Expense628,000USD467,000USD2,053,392USD753,714USD3,217,000USD9,247,000USD
    Net Interest Income-628,000USD0USD————
    Income Before Tax-8,639,000USD-159,000USD-10,941,365USD-2,009,180USD3,424,000USD-59,335,000USD
    Tax Provision0USD0USD————
    Net Income-45,006,000USD-168,000USD-11,137,943USD-2,449,390USD2,985,000USD-59,335,000USD
    Net Income From Continuing Ops-8,639,000USD0USD————
    Ebit-11,530,000USD308,000USD-8,755,448USD-1,166,410USD6,641,000USD-50,088,000USD
    Ebitda-11,499,000USD438,000USD-7,051,772USD-539,401USD8,305,000USD-48,340,000USD
    Depreciation And Amortization31,000USD130,000USD1,703,676USD627,009USD1,664,000USD1,748,000USD
    Reconciled Depreciation31,000USD4,387,000USD————
    Total Other Income Expense Net2,891,000USD5,808,000USD-5,133,850USD-842,770USD20,703,000USD-32,013,000USD
    Research Development—100,000USD————
    Unclassified Operating Expenses—18,726,000USD—1,330,042USD30,983,000USD41,673,000USD
    Income Tax Expense—9,000USD196,577USD440,209USD37,000USD—
    Selling And Marketing Expenses——2,947,932USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-06-30 · USDQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USD
    Total Assets145,357,000USD43,364,000USD27,053,000USD8,402,000USD33,985,000USD10,625,078USD15,801,000USD17,172,000USD
    Cash And Equivalents35,186,000USD———————
    Cash And Short Term Investments42,688,000USD26,070,000USD13,060,000USD1,309,000USD912,000USD790,208USD3,066,000USD4,743,000USD
    Short Term Investments7,502,000USD5,527,000USD——————
    Total Current Assets65,242,000USD43,149,000USD18,837,000USD8,126,000USD24,527,000USD10,097,577USD15,001,000USD16,326,000USD
    Other Current Assets2,254,000USD9,780,000USD1,403,000USD794,000USD10,337,000USD2,856,430USD325,000USD477,000USD
    Other Non Current Assets125,000USD———————
    Total Liabilities2,368,000USD———————
    Total Current Liabilities2,368,000USD25,078,000USD23,529,000USD3,543,000USD74,108,000USD5,086,665USD7,148,000USD6,852,000USD
    Other Current Liabilities1,091,000USD———————
    Total Stockholder Equity142,989,000USD18,286,000USD3,524,000USD407,000USD-45,880,000USD5,534,937USD8,648,000USD10,299,000USD
    Total Equity Including Noncontrolling Interest142,989,000USD———————
    Long Term Debt0USD——4,452,000USD————
    Net Receivables3,629,000USD5,213,000USD3,056,000USD3,945,000USD8,146,000USD3,315,124USD7,741,000USD7,176,000USD
    Inventory2,611,000USD2,086,000USD1,318,000USD2,078,000USD5,132,000USD3,135,815USD3,869,000USD3,930,000USD
    Property Plant Equipment Net9,000USD76,000USD73,000USD108,000USD7,787,000USD116,759USD202,000USD236,000USD
    Intangible Assets79,981,000USD—7,996,000USD1,124,000USD1,124,000USD—7,001,000USD—
    Accounts Payable1,277,000USD952,000USD1,247,000USD2,147,000USD38,397,000USD3,085,776USD3,137,000USD3,217,000USD
    Common Stock1,174,000USD419,000USD102,000USD31,000USD21,000USD2,084USD2,000USD2,000USD
    Retained Earnings-42,063,000USD-37,923,000USD-31,542,000USD-22,928,000USD-98,424,000USD-224,117,704USD-321,510,000USD-319,993,000USD
    Total Liab—25,078,000USD23,529,000USD7,995,000USD79,865,000USD5,090,141USD7,153,000USD6,873,000USD
    Other Current Liab—1,510,000USD1,254,000USD1,375,000USD4,463,000USD1,114,772USD1,035,000USD1,631,000USD
    Capital Stock—419,000USD102,000USD31,000USD—3,000USD——
    Cash—20,543,000USD13,060,000USD1,309,000USD912,000USD790,208USD3,066,000USD4,743,000USD
    Net Debt—2,073,000USD7,968,000USD3,164,000USD36,093,000USD99,384USD-585,000USD-2,718,000USD
    Short Term Debt—22,616,000USD21,028,000USD21,000USD31,248,000USD886,117USD2,476,000USD2,004,000USD
    Short Long Term Debt—22,616,000USD21,028,000USD——1,228,000USD——
    Short Long Term Debt Total—22,616,000USD21,028,000USD4,473,000USD37,005,000USD889,592USD2,481,000USD2,025,000USD
    Property Plant Equipment Gross—260,000USD540,000USD560,000USD—588,000USD——
    Common Stock Shares Outstanding—299,067,382shares33,737,015shares20,401,138shares20,401,138shares2,605,843shares1,830,097shares2,085,715shares
    Non Current Assets Total—215,000USD8,216,000USD276,000USD9,458,000USD527,501USD800,000USD846,000USD
    Non Current Liabilities Total—0USD0USD4,452,000USD5,757,000USD3,476USD5,000USD20,999USD
    Non Currrent Assets Other—139,000USD147,000USD168,000USD547,000USD129,270USD193,000USD205,000USD
    Net Working Capital—18,071,000USD-4,692,000USD4,583,000USD—7,210,000USD——
    Unclassified Current Liabilities—-22,616,000USD-21,028,000USD——-1,228,000USD——
    Unclassified Equity—55,371,000USD34,862,000USD23,273,000USD38,642,000USD229,647,557USD330,156,000USD330,290,000USD
    Unclassified Non Current Assets———-1,124,000USD——-7,001,000USD—
    Accumulated Other Comprehensive Income————13,881,000USD0USD——
    Unclassified Non Current Liabilities————5,757,000USD———
    Good Will—————281,472USD405,000USD405,000USD
    Current Deferred Revenue——————500,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USD
    Total Assets8,402,000USD15,801,000USD64,511,426USD34,785,252USD77,423,000USD51,253,000USD
    Other Current Assets794,000USD825,000USD10,287,579USD5,745,172USD2,940,000USD4,074,000USD
    Total Liab7,995,000USD7,153,000USD70,801,183USD33,857,771USD19,548,000USD79,355,000USD
    Total Stockholder Equity407,000USD-55,119,000USD-6,289,757USD927,481USD57,875,000USD-28,102,000USD
    Other Current Liab1,375,000USD-72,012,000USD5,328,956USD1,891,889USD1,654,000USD42,900,000USD
    Common Stock31,000USD22,000USD8,804,040USD7,267,079USD29,000USD52,000USD
    Capital Stock31,000USD22,000USD————
    Retained Earnings-22,928,000USD-70,031,000USD-17,584,521USD-6,339,598USD-259,255,999USD-260,641,000USD
    Cash1,309,000USD3,066,000USD2,068,853USD1,658,750USD28,942,000USD3,989,000USD
    Cash And Short Term Investments1,309,000USD3,066,000USD2,068,853USD1,658,750USD28,942,000USD3,989,000USD
    Total Current Assets8,126,000USD15,001,000USD25,133,996USD14,799,154USD43,919,000USD17,563,000USD
    Total Current Liabilities3,543,000USD7,148,000USD65,502,414USD22,035,824USD7,341,000USD54,576,000USD
    Net Debt3,164,000USD-585,000USD37,313,728USD16,192,185USD-18,613,000USD28,979,000USD
    Short Term Debt21,000USD38,989,000USD35,810,312USD6,558,978USD909,000USD8,189,000USD
    Short Long Term Debt Total4,473,000USD45,308,000USD39,382,581USD17,850,935USD10,329,000USD32,968,000USD
    Long Term Debt4,452,000USD696,000USD————
    Net Receivables3,945,000USD7,741,000USD7,059,135USD3,379,767USD6,792,000USD4,631,000USD
    Inventory2,078,000USD3,369,000USD5,718,429USD4,015,465USD5,245,000USD4,869,000USD
    Accounts Payable2,147,000USD39,842,000USD24,363,146USD13,584,957USD4,553,000USD3,137,000USD
    Property Plant Equipment Net108,000USD12,521,000USD10,637,295USD7,359,031USD425,000USD597,000USD
    Property Plant Equipment Gross560,000USD17,697,000USD————
    Common Stock Shares Outstanding21,107,043shares1,615,487shares12,388,467shares704,183shares497,785shares185,925shares
    Non Current Assets Total276,000USD800,000USD39,377,430USD19,986,098USD33,504,000USD33,690,000USD
    Non Current Liabilities Total4,452,000USD7,580,000USD5,298,769USD11,821,947USD12,206,999USD24,779,000USD
    Non Currrent Assets Other168,000USD-18,872,000USD473,409USD61,544USD116,000USD1,364,000USD
    Net Working Capital4,583,000USD-67,667,000USD————
    Unclassified Equity23,273,000USD12,469,000USD——317,101,999USD232,487,000USD
    Intangible Assets—7,001,000USD9,786,193USD3,783,051USD11,586,000USD13,115,000USD
    Good Will—405,000USD18,480,533USD8,782,472USD18,614,000USD18,614,000USD
    Current Deferred Revenue—29,000USD——225,000USD350,000USD
    Short Long Term Debt—37,520,000USD————
    Accumulated Other Comprehensive Income—2,399,000USD2,490,723USD0USD——
    Unclassified Non Current Assets—-19,127,000USD——2,763,000USD—
    Unclassified Current Liabilities—-109,232,000USD————
    Unclassified Non Current Liabilities—6,884,000USD5,298,769USD11,821,947USD12,206,999USD24,779,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Net Income-6,381,000USD-8,614,000USD21,106,000USD-15,133,000USD-964,000USD-1,517,000USD1,526,000USD-3,115,000USD
    Depreciation-76,000USD15,000USD-2,892,000USD1,800,000USD26,000USD31,000USD31,000USD—
    Stock Based Compensation0USD961,000USD-1,245,000USD—280,000USD424,000USD——
    Other Non Cash Items4,434,000USD5,588,000USD-10,200,000USD13,333,000USD43,000USD63,000USD-2,547,000USD3,115,000USD
    Change To Account Receivables-716,000USD897,000USD2,437,000USD—558,000USD365,000USD-1,417,000USD—
    Change To Inventory-768,000USD760,000USD-1,431,000USD—-643,000USD61,000USD-104,000USD—
    Change In Working Capital-1,599,000USD85,000USD154,000USD-997,000USD997,000USD249,000USD-1,211,000USD—
    Total Cash From Operating Activities-3,622,000USD-2,922,000USD7,601,000USD-16,128,000USD384,000USD-1,168,000USD-2,203,000USD—
    Capital Expenditures0USD-8,460,000USD0USD-7,000USD-7,000USD-12,000USD-11,000USD0USD
    Free Cash Flow-3,622,000USD-2,922,000USD7,601,000USD-16,121,000USD377,000USD-1,180,000USD-2,214,000USD—
    Total Cashflows From Investing Activities-7,033,000USD-8,460,000USD-7,375,000USD14,407,000USD-1,127,000USD-773,000USD-1,461,000USD—
    Net Borrowings0USD-1,623,000USD9,609,000USD—-1,186,000USD-4,224,000USD——
    Total Cash From Financing Activities21,143,000USD23,133,000USD9,017,000USD—-1,186,000USD264,000USD5,114,000USD—
    Sale Purchase Of Stock-21,780,000USD—0USD——-206,000USD——
    Issuance Of Capital Stock43,298,000USD25,006,000USD-9,238,000USD——674,000USD——
    Change In Cash7,483,000USD12,148,000USD397,000USD-225,000USD-1,929,000USD-1,677,000USD1,450,000USD—
    Begin Period Cash Flow13,060,000USD912,000USD912,000USD1,137,000USD3,066,000USD4,743,000USD3,293,000USD2,861,488USD
    End Period Cash Flow20,543,000USD13,060,000USD1,309,000USD912,000USD1,137,000USD3,066,000USD4,743,000USD3,066,000USD
    Other Cashflows From Investing Activities-4,789,000USD—-7,375,000USD14,400,000USD-1,120,000USD-761,000USD-1,450,000USD—
    Other Cashflows From Financing Activities-375,000USD-250,000USD8,646,000USD—-824,263USD———
    Unclassified Investing Cash Flow-2,244,000USD———1,127,000USD———
    Unclassified Financing Cash Flow43,298,000USD—-9,238,000USD——4,694,000USD——
    Unclassified Operating Cash Flow———-15,131,000USD————
    Investments————-1,127,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USD
    Net Income-8,639,000USD-43,054,000USD-11,137,943USD-2,449,390USD2,985,000USD-59,335,000USD
    Depreciation31,000USD4,387,000USD2,872,834USD1,330,040USD1,664,000USD1,748,000USD
    Stock Based Compensation4,472,000USD3,667,000USD2,947,932USD———
    Other Non Cash Items133,000USD31,338,000USD15,347,771USD7,313,327USD-14,658,000USD49,822,000USD
    Change To Account Receivables5,406,000USD-1,148,000USD-4,963,040USD565,466USD-2,141,000USD1,193,000USD
    Change To Inventory496,000USD2,742,000USD-746,554USD-1,885,371USD-642,000USD1,454,000USD
    Change In Working Capital332,000USD426,000USD-6,164,594USD-1,526,977USD-1,849,000USD175,000USD
    Total Cash From Operating Activities-8,143,000USD-4,357,000USD3,866,000USD4,667,000USD-11,858,000USD-7,590,000USD
    Capital Expenditures-2,076,000USD-41,000USD-1,270,762USD-244,721USD-353,000USD-151,000USD
    Free Cash Flow-8,143,000USD-4,398,000USD1,575,568USD3,134,321USD-12,211,000USD-7,741,000USD
    Total Cashflows From Investing Activities5,905,000USD-2,252,000USD-19,780,000USD-6,826,870USD-353,000USD-151,000USD
    Net Borrowings3,662,000USD675,000USD————
    Total Cash From Financing Activities12,171,000USD5,220,000USD16,433,000USD3,798,980USD37,164,000USD9,196,000USD
    Sale Purchase Of Stock-137,000USD-206,000USD——-1,601,000USD—
    Issuance Of Capital Stock0USD919,000USD————
    Change In Cash-1,757,000USD-1,389,000USD519,000USD1,658,750USD24,953,000USD1,455,000USD
    Begin Period Cash Flow3,066,000USD4,455,000USD1,658,750USD28,942,000USD3,989,000USD2,534,000USD
    End Period Cash Flow1,309,000USD3,066,000USD2,068,853USD1,658,750USD28,942,000USD3,989,000USD
    Other Cashflows From Investing Activities5,940,000USD83,000USD-5,280,354USD-914,450USD——
    Other Cashflows From Financing Activities-4,803,922USD-1,000USD5,056,513USD-107,881USD——
    Unclassified Operating Cash Flow-4,472,000USD-1,121,000USD————
    Unclassified Investing Cash Flow2,041,000USD-2,294,000USD-13,228,884USD-5,667,699USD——
    Unclassified Financing Cash Flow13,449,922USD4,752,000USD11,376,487USD3,906,861USD38,765,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-03-31GeographyAsia339,000USD0001493152-26-023072
    Q2 2026Quarterly · 2026-03-31GeographyCanada165,000USD0001493152-26-023072
    Q2 2026Quarterly · 2026-03-31GeographyUnited States2,935,000USD0001493152-26-023072
    Q1 2026Quarterly · 2025-12-31GeographyAsia124,000USD0001493152-26-006816
    Q1 2026Quarterly · 2025-12-31GeographyCanada50,000USD0001493152-26-006816
    Q1 2026Quarterly · 2025-12-31GeographyUnited States2,633,000USD0001493152-26-006816
    FY 2025Yearly · 2025-09-30GeographyOther196,000USD0001493152-25-026452
    FY 2025Yearly · 2025-09-30GeographyTaiwan833,000USD0001493152-25-026452
    FY 2025Yearly · 2025-09-30GeographyUnited States5,505,000USD0001493152-25-026452
    Q3 2025Quarterly · 2025-06-30GeographyCanada8,774,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30GeographyUnited States2,673,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductClinical Trial213,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductConsumer Packaged Goods2,673,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductInfusion Services207,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductOther Service Revenue1,228,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductPatient Support Program193,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductRetail Pharmacy6,790,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductSpecialty Clinics142,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30ProductWholesale Distribution Of Drugs And Other Medications1,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30SegmentConsumer Products2,673,000USD0001493152-25-016260
    Q3 2025Quarterly · 2025-06-30SegmentHealth Solutions8,774,000USD0001493152-25-016260
    Q2 2025Quarterly · 2025-03-31GeographyChina3,262,000USD0001641172-25-011011
    Q2 2025Quarterly · 2025-03-31GeographyOther733,000USD0001641172-25-011011
    Q2 2025Quarterly · 2025-03-31GeographyUnited States3,164,000USD0001641172-25-011011
    FY 2024Yearly · 2024-12-31GeographyChina12,808,000USD0001641172-25-001558
    FY 2024Yearly · 2024-12-31GeographyOther4,372,000USD0001641172-25-001558
    FY 2024Yearly · 2024-12-31GeographyUnited States17,795,000USD0001641172-25-001558
    Q3 2024Quarterly · 2024-06-30ProductClinical Trial7,000USD0001493152-25-016260
    Q3 2024Quarterly · 2024-06-30ProductInfusion Services428,000USD0001493152-25-016260
    Q3 2024Quarterly · 2024-06-30ProductOther Service Revenue179,000USD0001493152-25-016260
    Q3 2024Quarterly · 2024-06-30ProductPatient Support Program262,000USD0001493152-25-016260
    Q3 2024Quarterly · 2024-06-30ProductRetail Pharmacy41,438,000USD0001493152-25-016260
    Q3 2024Quarterly · 2024-06-30ProductSpecialty Clinics111,000USD0001493152-25-016260
    Q3 2024Quarterly · 2024-06-30ProductWholesale Distribution Of Drugs And Other Medications245,000USD0001493152-25-016260
    Q2 2024Quarterly · 2024-03-31GeographyChina2,190,000USD0001641172-25-011011
    Q2 2024Quarterly · 2024-03-31GeographyOther683,000USD0001641172-25-011011
    Q2 2024Quarterly · 2024-03-31GeographyUnited States5,030,000USD0001641172-25-011011
    FY 2023Yearly · 2023-12-31GeographyChina11,000,000USD0001641172-25-001558
    FY 2023Yearly · 2023-12-31GeographyOther4,024,000USD0001641172-25-001558
    FY 2023Yearly · 2023-12-31GeographyUnited States23,568,000USD0001641172-25-001558

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.